Clinical Trials Browser

Unknown × UNKNOWN × nimotuzumab × Clear all

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms